During a symposium beginning Saturday at 8:00 a.m. PT in Ballroom 20A-C, panelists including Ronnie Aronson, MD, will discuss CGM’s potential use as a preventative tool and its role for people living with diabetes who are treated with insulin compared to those who are not. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Coming up: Continuous Glucose Monitoring in Type 2 Diabetes—Are We There Yet?
